85.43

0.60% 0.51

After Hours: 85.43

Haemonetics Corp (HAE)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Haemonetics Corp stock is traded at $85.43, with a volume of 561.30K. It is up +0.60% in the last 24 hours and up +14.10% over the past month. Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Previous Close:

$84.92

Open:

$85.25

24h Volume:

561.30K

Relative Volume:

0.94

Market Cap:

$4.29B

Revenue:

$1.33B

Net Income/Loss:

$114.89M

P/E Ratio:

34.31

EPS:

2.49

Net Cash Flow:

$70.97M

1W Performance:

-5.86%

1M Performance:

+14.10%

6M Performance:

-8.33%

1Y Performance:

+3.61%

1-Day Range:

$84.42

$86.68

1-Week Range:

$83.32

$91.43

52-Week Range:

$70.25

$97.97

Haemonetics Corp Stock (HAE) Company Profile

Name

Haemonetics Corp

Sector

Healthcare (1195)

Industry

Medical Instruments & Supplies (58)

Phone

(781) 848-7100

Address

125 SUMMER STREET, BOSTON, MA

Employee

3,657

Twitter

@HaemoneticsCorp

Next Earnings Date

2024-11-07

Latest SEC Filings

HAE's Discussions on Twitter

Compare HAE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HAE	85.43	4.29B	1.33B	114.89M	70.97M	2.49
ISRG	550.62	194.93B	7.87B	2.24B	586.00M	4.25
BDX	225.45	64.77B	20.18B	1.73B	3.07B	5.51
ALC	85.57	42.36B	9.76B	1.16B	665.00M	0.72
RMD	243.60	35.51B	4.81B	1.11B	1.35B	6.16
WST	320.88	22.81B	2.88B	499.60M	321.60M	7.41

Haemonetics Corp Stock (HAE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-13-22	Initiated	Mizuho	Buy
Jan-27-22	Downgrade	Needham	Buy → Hold
Dec-15-21	Downgrade	Citigroup	Buy → Neutral
Aug-17-21	Resumed	Raymond James	Outperform
Jun-17-21	Initiated	Citigroup	Buy
May-14-21	Upgrade	CJS Securities	Market Perform → Market Outperform
Apr-20-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-19-21	Downgrade	CJS Securities	Market Outperform → Market Perform
Feb-03-21	Upgrade	Barrington Research	Mkt Perform → Outperform
Jan-21-21	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-05-20	Upgrade	Barrington Research	Mkt Perform → Outperform
May-06-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-31-20	Upgrade	CJS Securities	Market Perform → Market Outperform
Jan-10-20	Initiated	Needham	Buy
Aug-07-19	Reiterated	Barrington Research	Outperform
May-14-19	Upgrade	Raymond James	Mkt Perform → Outperform
May-08-19	Reiterated	Barrington Research	Outperform
Aug-09-18	Reiterated	Barrington Research	Outperform
Feb-07-18	Reiterated	Barrington Research	Outperform
Jan-02-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-08-17	Reiterated	Barrington Research	Outperform
Aug-08-17	Upgrade	Barrington Research	Mkt Perform → Outperform
Jul-13-17	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Feb-07-17	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-08-16	Upgrade	Barrington Research	Mkt Perform → Outperform
Nov-07-16	Reiterated	The Benchmark Company	Hold
Sep-20-16	Downgrade	CJS Securities	Market Outperform → Market Perform
Aug-15-16	Downgrade	Sidoti	Buy → Neutral
Aug-02-16	Reiterated	Jefferies	Buy
Aug-02-16	Reiterated	The Benchmark Company	Hold

View All

Haemonetics Corp Stock (HAE) Latest News

Nov 21, 2024

Haemonetics Co. (NYSE:HAE) Shares Bought by Connor Clark & Lunn Investment Management Ltd. - MarketBeat

Nov 21, 2024

Leukapheresis Market 2024 Opportunity, Challenge, Drivers, - openPR

Nov 21, 2024

[Latest] Global Apheresis Equipment Market Size/Share Worth USD 13,169.1 Million by 2033 at a 12.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.

Nov 21, 2024

Nov 18, 2024

Haemonetics Co. (NYSE:HAE) Holdings Increased by Thrivent Financial for Lutherans - MarketBeat

Nov 18, 2024

Nov 17, 2024

Principal Financial Group Inc. Reduces Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat

Nov 17, 2024

Nov 16, 2024

Haemonetics (NYSE:HAE) Given Buy Rating at Needham & Company LLC - MarketBeat

Nov 16, 2024

Nov 15, 2024

Royce & Associates LP Has $97.30 Million Position in Haemonetics Co. (NYSE:HAE) - MarketBeat

Nov 15, 2024

Aigen Investment Management LP Makes New Investment in Haemonetics Co. (NYSE:HAE) - MarketBeat

Nov 15, 2024

Nov 14, 2024

T. Rowe Price Investment Management, Inc. Expands Stake in Haemo - GuruFocus.com

Nov 14, 2024

Nov 13, 2024

Capital Research Global Investors Adjusts Stake in Haemonetics C - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

Here's Why Haemonetics (HAE) is a Strong Value Stock - Yahoo Finance

Nov 12, 2024

Nov 11, 2024

Wall Street Analysts Think Haemonetics (HAE) Could Surge 25.58%: Read This Before Placing a Bet - Yahoo Finance

Nov 11, 2024

Haemonetics Corporation (NYSE:HAE) Q2 2025 Earnings Call Transcript - Insider Monkey

Nov 11, 2024

Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand - Yahoo Finance

Nov 11, 2024

Nov 09, 2024

Barrington Research Reaffirms Outperform Rating for Haemonetics (NYSE:HAE) - MarketBeat

Nov 09, 2024

Haemonetics (NYSE:HAE) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat

Nov 09, 2024

Creative Planning Reduces Stock Holdings in Haemonetics Co. (NYSE:HAE) - Defense World

Nov 09, 2024

Raymond James Upgrades Haemonetics (HAE) - MSN

Nov 09, 2024

Nov 08, 2024

Raymond James upgrades haemonetics stock, highlights overlooked growth drivers - Investing.com

Nov 08, 2024

Wellington Management Group LLP Increases Stake in Haemonetics C - GuruFocus.com

Nov 08, 2024

Compared to Estimates, Haemonetics (HAE) Q2 Earnings: A Look at Key Metrics - Yahoo Canada Finance

Nov 07, 2024

Haemonetics Corp Q2 FY2025 Earnings: Revenue Hits $345.5M, EPS a - GuruFocus.com

Nov 07, 2024

Haemonetics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 28, 2024 - Marketscreener.com

Nov 07, 2024

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website - Quantisnow

Nov 07, 2024

Nov 06, 2024